FDA Breakthrough Designation for a Urine Test for a Treatable Dementia Cause
BioStream's urine test received FDA Breakthrough Device Designation to help diagnose idiopathic normal pressure hydrocephalus (iNPH). The condition...

Created by Judy Gannon
Peer‑reviewed dementia research, lifestyle guidance, and uplifting personal stories
Explore the latest content tracked by Dementia Prevention Digest
BioStream's urine test received FDA Breakthrough Device Designation to help diagnose idiopathic normal pressure hydrocephalus (iNPH). The condition...
Several barriers stack on top of each other and can delay dementia diagnosis:
The Surrey Cognitive Health Initiative pairs a clinical assessment with lifestyle changes, run in partnership with Bryn Mawr Hospital – Main Line...
Research is underway in the Triad at Wake Forest's Sticht Center, and Dr. Laura Baker calls the new findings "potentially life altering". Here's how...
A new study suggests simple visual tests may be a useful research signal for early cognitive change. Researchers at Anglia Ruskin University studied...
AR1001, a lower-dose version of mirodenafil, an erectile dysfunction drug used in Korea since 2007, is an early lead rather than an established...
Eye-based approaches are being explored as a possible aid to clinical evaluation, not a replacement for it.
Lawmakers are pushing for passage of the ASAP Act, which would authorize Medicare to cover FDA-approved early detection blood tests. It is a...
Limited schooling is one of 14 modifiable risk factors linked to roughly 45% of dementia cases worldwide, according to The Lancet. Yet Zaldy Tan, of...
A new blood test measures eMTBR-tau, a marker reflecting how much tau tangle buildup has accumulated in the brain. Here's what it may add:
A £4.46 million gift from the Michael Uren Foundation will fund three new dementia research projects at Imperial College London, building on its...
A blood result can estimate future risk, but it cannot diagnose Alzheimer's.
Too many people notice cognitive changes without a timely diagnosis, leaving families uncertain about what to do next. Earlier detection can give...
A free community screening can be a first step toward care. Patients at Texas Tech's Amarillo health sciences center answered tablet questions testing...
C2N Diagnostics has launched a plasma assay that quantifies six amyloid-beta variants from a single sample. It is available for research use only.
-...
A trial reportedly found that a medication working similarly to erectile dysfunction pills may mitigate memory loss in some dementia patients. The...
A large review found people with Type 2 diabetes were 53 percent more likely to develop Alzheimer's, pooling 40 observational studies. That relative...
The MIND diet was developed specifically for brain health, blending Mediterranean and DASH elements with changes based on brain research. Rather than...